Yahoo Finance

EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide

PROVIDENCE, R.I., Dec. 9, 2025 /PRNewswire/ -- EpiVax, Inc., with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators, announces the publication of a study ...
BioProcess International

From Identification to Justification: A Practical and Consolidated Strategy for Elemental-Impurity Risk Management in Biomanufacturing

Elemental impurity risk management can help biomanufacturers to maintain regulatory alignment and ensure patient safety.
Morningstar

EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide

PROVIDENCE, R.I., Dec. 8, 2025 /PRNewswire/ -- EpiVax, Inc., with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators ...
Pharmabiz

EpiVax and US FDA scientists publish new insights on immunogenicity risks of peptide-related impurities in generic teriparatide

EpiVax, Inc., with US Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators, announces the publication of a study titled “Immunogenicity Risk Assessment of ...